-
2 March: Expands senior management team.
http://stocknessmonster.com/news-ite...E=ASX&N=361578
Bought on 17 Sept 2004 for 84 cents; now $1.30
-
-
-
Member
PXS is having a good run atm...nice chart...apparently US investors are buying in on
-
Yes, I am very pleased with it.
There is a somewhat constant push, sometimes slow but then picking up speed.
See how we go.
Gerry
-
Hit $1.85, retraced, now $1.73
Graph still steep:
http://bigcharts.marketwatch.com/jav...XS&time=&freq=
STO was 100, now 83
-
US FDA GRANTS BRONCHITOL ORPHAN DRUG STATUS FOR
TREATMENT OF CYSTIC FIBROSIS
http://stocknessmonster.com/news-ite...E=ASX&N=375529
-
Commitments Test Entity - Fourth Quarter Report
Outflow: $3.05 mill
Cash: $33.4 mill
Share price: 1.86
-
-
Lists ADRs on NASDAQ
http://stocknessmonster.com/news-ite...E=ASX&N=378990
"Pharmaxis Ltd (ASX:PXS), announced today that it has received approval from NASDAQ to list its American Depositary Receipts (ADRs) on the NASDAQ National Market under the symbol PXSL (CUSIP number: 71715J
10 5).
No new shares will be issued in conjunction with the listing and one ADR will continue to be equivalent to 15 Pharmaxis ordinary shares. The Bank of New York remains the depositary bank".
Share price: $2.07
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks